Ether phospholipids and glycosylinositolphospholipids are not required for amastigote virulence or for inhibition of macrophage activation by Leishmania major

被引:90
|
作者
Zufferey, R
Allen, S
Barron, T
Sullivan, DR
Denny, PW
Almeida, IC
Smith, DF
Turco, SJ
Ferguson, MAJ
Beverley, SM
机构
[1] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
[2] Univ Dundee, Wellcome Trust Bioctr, Dundee DD1 4HN, Scotland
[3] Univ Kentucky, Med Ctr, Dept Biochem, Lexington, KY 40506 USA
[4] Univ London Imperial Coll Sci Technol & Med, Wellcome Trust Labs Mol Parasitol, Dept Biol Sci, London SW7 1AZ, England
[5] Univ Sao Paulo, Dept Parasitol, BR-05508900 Sao Paulo, Brazil
关键词
D O I
10.1074/jbc.M308063200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ether phospholipids are major components of the membranes of humans and Leishmania. In protozoan parasites they occur separately or as part of the glycosylphosphatidylinositol (GPI) anchor of molecules implicated in virulence, such as lipophosphoglycan (LPG), smaller glycosylinositolphospholipids (GIPLs), and GPI-anchored proteins. We generated null mutants of the Leishmania major alkyldihydroxyacetonephosphate synthase ( ADS), the first committed step of ether lipid synthesis. Enzymatic analysis and comprehensive mass spectrometric analysis showed that ads1(-) knock-outs lacked all ether phospholipids, including plasmalogens, LPG, and GIPLs. Leishmania ads1(-) thus represents the first ether lipid- synthesizing eukaryote for which a completely null mutant could be obtained. Remarkably ads1(-) grew well and maintained lipid rafts (detergent-resistant membranes). In virulence tests it closely resembled LPG-deficient L. major, including sensitivity to complement and an inability to survive the initial phase of macrophage infection. Likewise it retained the ability to inhibit host cell signaling and to form infectious amastigotes from the few parasites surviving the establishment defect. These findings counter current proposals that GIPLs are required for amastigote survival in the mammalian host or that parasite lyso-alkyl or alkylacyl-GPI anchors are solely responsible for inhibition of macrophage activation.
引用
收藏
页码:44708 / 44718
页数:11
相关论文
共 31 条
  • [21] Monarch-1 Activation in Murine Macrophage Cell Line (J774 A.1) Infected with Iranian Strain of Leishmania major
    Fata, A.
    Mahmoudian, M. R.
    Varasteh, A.
    Sankian, M.
    IRANIAN JOURNAL OF PARASITOLOGY, 2013, 8 (02) : 207 - 211
  • [22] INHIBITION OF INTERFERON GAMMA-INDUCED MACROPHAGE MICROBICIDAL ACTIVITY AGAINST LEISHMANIA-MAJOR BY LIPOSOMES - INHIBITION IS DEPENDENT UPON COMPOSITION OF PHOSPHOLIPID HEADGROUPS AND FATTY-ACIDS
    GILBREATH, MJ
    FOGLER, WE
    SWARTZ, GM
    ALVING, CR
    MELTZER, MS
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1989, 11 (02): : 103 - 110
  • [23] Primed Antigen-Specific CD4+ T Cells Are Required for NK Cell Activation In Vivo upon Leishmania major Infection
    Bihl, Franck
    Pecheur, Julien
    Breart, Beatrice
    Poupon, Gwenola
    Cazareth, Julie
    Julia, Valerie
    Glaichenhaus, Nicolas
    Braud, Veronique M.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (04): : 2174 - 2181
  • [24] Golgi-Located NTPDase1 of Leishmania major Is Required for Lipophosphoglycan Elongation and Normal Lesion Development whereas Secreted NTPDase2 Is Dispensable for Virulence
    Sansom, Fiona M.
    Ralton, Julie E.
    Sernee, M. Fleur
    Cohen, Alice M.
    Hooker, David J.
    Hartland, Elizabeth L.
    Naderer, Thomas
    McConville, Malcolm J.
    PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (12):
  • [25] Inhibition of anti-inflammatory cytokines, IL-10 and TGF-?, in Leishmania major infected macrophage by miRNAs: A new therapeutic modality against leishmaniasis
    Hamidi, Faezeh
    Mohammadi-Yeganeh, Samira
    Hoseini, Mostafa Haji Molla
    Tabaei, Seyyed Javad Seyyed
    Taghipour, Niloofar
    Lasjerdi, Zohreh
    Gholamrezaei, Mostafa
    Haghighi, Ali
    MICROBIAL PATHOGENESIS, 2021, 153
  • [26] Effect of insulin-like growth factor-I on Leishmania amazonensis promastigote arginase activation and reciprocal inhibition of NOS2 pathway in macrophage in vitro
    Vendrame, C. M. V.
    Carvalho, M. D. T.
    Rios, F. J. O.
    Manuli, E. R.
    Petitto-Assis, F.
    Goto, H.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2007, 66 (2-3) : 287 - 296
  • [27] PPAR Activation Induces M1 Macrophage Polarization via cPLA2-COX-2 Inhibition, Activating ROS Production against Leishmania mexicana
    Diaz-Gandarilla, J. A.
    Osorio-Trujillo, C.
    Hernandez-Ramirez, V. I.
    Talamas-Rohana, P.
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [28] RESPONSE OF MURINE LEUKEMIA TO COMBINED BCNU MALEIC ANHYDRIDE VINYL ETHER (MVE) ADJUVANT THERAPY AND CORRELATION WITH MACROPHAGE ACTIVATION BY MVE IN THE INVITRO GROWTH-INHIBITION ASSAY
    DEAN, JH
    PADARATHSINGH, ML
    KEYS, L
    CANCER TREATMENT REPORTS, 1978, 62 (11): : 1807 - 1816
  • [29] PAF-AGONISTIC AND -ANTAGONISTIC BEHAVIOR OF NEW SYNTHETIC ETHER PHOSPHOLIPIDS .2. RELATIONSHIPS BETWEEN CHEMICAL-STRUCTURE AND INHIBITION OF PAF-INDUCED HUMAN PLATELET ACTIVATION
    OSTERMANN, G
    HOFMANN, B
    KERTSCHER, HP
    TILL, U
    JOURNAL OF LIPID MEDIATORS, 1991, 3 (02): : 225 - 237
  • [30] SUSCEPTIBILITY OF INBRED MICE TO LEISHMANIA-MAJOR INFECTION - GENETIC-ANALYSIS OF MACROPHAGE ACTIVATION AND INNATE RESISTANCE TO DISEASE IN INDIVIDUAL PROGENY OF P/J (SUSCEPTIBLE) AND C3H/HEN (RESISTANT) MICE
    FORTIER, AH
    TONG, A
    NACY, CA
    INFECTION AND IMMUNITY, 1990, 58 (12) : 4149 - 4152